Fernando Arevalo, MD

Call
Website

Photos

1800 Orleans St Lbby
Baltimore, MD 21287
+1 (410) 955-5080
https://profiles.hopkinsmedicine.org
J. Fernando Arevalo, M.D., Ph.D, F.A.C.S., is chairman of ophthalmology at Johns Hopkins Bayview Medical Center, and the Edmund F. and Virginia Ball Professor of Ophthalmology, specializing in vitreoretinal diseases. A gifted surgeon, he has performed more than 9000 retinal detachment operations. He also teaches and conducts clinical research that has led to advances in the treatment of complex retinal detachments, vitreo-retinal complications of refractive surgery, diabetic retinopathy and age-related macular degeneration (combination therapy and anti-angiogenics).Dr. Arevalo, completed his medical and ophthalmology training in Caracas, Venezuela, his native country, before traveling to Bogota, Colombia for a two-year Retina and Vitreous fellowship at the Barraquer Institute and the Fundacion Oftalmogica Nacional (University of El Rosario) in 1992-1993. After this intensive training, he traveled to the USA for a 2-year Retina and Vitreous/Uveitis and Intraocular Inflammation fellowship at the University of California, San Diego from 1993-1995 under the mentoring of Dr. William Freeman. The following year, Dr. Arevalo went to Philadelphia, Pennsylvania, for his Ocular Oncology fellowship at Wills Eye Hospital under the mentoring of Drs. Jerry and Carol Shields.Dr. Arevalo returned to Venezuela (1996), where he was appointed to the rank of Chairman of Ophthalmology at the Clinica Oftalmologica Centro Caracas in Caracas, Venezuela, and Professor of Ophthalmology at the University of Los Andes, Merida, Venezuela. Dr. Arevalo has become recognized as one of the leading ophthalmologists in South America and in 2001 founded the Arevalo-Coutinho Foundation for Research in Ophthalmology. In 2011, he joined the faculty of the Wilmer Eye Institute as chief of the retina division at King Khaled Eye Specialist Hospital (KKESH), Wilmer's affiliate hospital in Saudi Arabia, prior to his appointment as chief of ophthalmology at Johns Hopkins Bayview Medical Center in 2015. In 2018, he obtained his doctorate in ophthalmology from Stellenbosch University in South Africa. As a clinical scientist, Dr. Arevalo has more than 1000 scientific publications (more than 300 on MEDLINE), 15 books, more than 900 scientific paper presentations, and more than 1300 invited lecture presentations in North-America, South-America, Central-America, Europe, Africa, and Asia that have led to international recognition and awards.Dr. Arevalo belongs to numerous scientific societies including the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, the Pan-American Association of Ophthalmology, the American Society of Retina Specialists, the Retina Society, the Macula Society, the Club Jules Gonin, the International Uveitis Study Group, the International Society of Ocular Oncology, Fellow of the American College of Surgeons, American Ophthalmological Society, and has a seat at the Academia Ophthalmologica Internationalis. Dr. Arevalo is a former President of the Pan-American Retina and Vitreous Society (2006-2008). Dr. Arevalo is currently the president of the Pan-American Association of Ophthalmology (PAAO) — a position he also held from 2017-2019. He is also a member of the Board of Directors of the Pan-American Ophthalmological Foundation (PAOF).If you would like to make a contribution using a credit card to support Dr. Fernando Arevalo's research please visit our secure online giving page by clicking here, and designate your gift Other - Dr. Fernando Arevalo.

Also at this address

Owner verified
See a problem?

You might also like

Chris Moonho Cho, MD

Chris Moonho Cho, MD

Dr. Christopher VandenBussche is a Professor of Pathology and Oncology at the Johns Hopkins University School of Medicine. He serves as the Director of the Pathology Residency Training Program and Associate Director of Cytopathology. He is the current chair of the College of American Pathologists Cytopathology Committee.
Samuel Chi-Hung Yiu, MD

Samuel Chi-Hung Yiu, MD

Samuel C. Yiu, M.D., Ph.D., is an associate professor of ophthalmology at the Wilmer Eye Institute, specializing in cornea and external eye diseases, cataracts and refractive surgery (LASIK). In addition, he is a nationally and internationally recognized specialist in ocular surface diseases and ocular surface reconstruction surgery.Dr. Yiu received his M.Sc. (applied biometry) and Ph.D. (physiology and biophysics) from the University of Southern California. He then completed a post-doctoral fellowship in lacrimal physiology at the Schepens Eye Institute at Harvard Medical School and went on to earn his M.D. from the University of Alberta in Canada. Dr. Yiu completed an internship and his ophthalmology residency at Dalhousie University in Halifax, Nova Scotia and a fellowship in cornea, external disease and refractive surgery at the University of Southern California’s Doheny Eye Institute. After serving as the director of Doheny’s Ocular Surface Center and co-director of Doheny’s cornea division, Dr. Yiu joined the Wilmer faculty in 2011 and spent two years as the chief of the cornea division at King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Riyadh, Saudi Arabia, before returning to Baltimore in 2013.
Jefferson Doyle, MD

Jefferson Doyle, MD

Jefferson Doyle, M.D., Ph.D., M.H.S. specializes in pediatric ophthalmology and genetic eye diseases and is the recipient of the 2023 Andreas C. Dracopoulos & Daniel Finkelstein, M.D. Rising Professorship in Ophthalmology. His main focus is pediatric and juvenile forms of cataracts, glaucoma, anterior segment dysgenesis, and ectopia lentis. His genetics interests include Marfan syndrome and related connective tissue disorders, complex inherited forms of strabismus in both children and adults (e.g. CFEOM, Duane syndrome), and pediatric retinal dystrophies.Dr. Doyle has published extensively on a number of genetic disorders over the past decade, holds several patents for novel therapeutic approaches to treat them, and has given many national and international talks about them. Dr. Doyle's main research focus is understanding the genetic causes and molecular mechanisms driving genetic diseases, and utilizing that knowledge to develop new therapeutic strategies for them.Over the past decade, he has played a significant role in advancing our understanding of Marfan syndrome and related connective tissue disorders. His work and that of collaborators has led to the discovery of the genetic causes of Shprintzen-Goldberg syndrome and Loeys-Dietz like syndrome. His work has also led to a much better understanding of the molecular mechanisms driving Marfan syndrome, and he holds two patents for novel therapeutic strategies to treat it.Part of his current work focuses on the identification of genes that protect people from developing a number of genetic disorders, and leveraging that knowledge to develop new therapies for those diseases. He also has an interest in pediatric myopia, and has ongoing pre-clinical studies seeking to understand the mechanisms that may drive it and the development of novel therapeutic strategies to treat it.
United States›Maryland›Baltimore›Fernando Arevalo, MD

Yext